Global Botanical and Plant Derived Drugs Market Growth (Status and Outlook) 2023-2029

Global Botanical and Plant Derived Drugs Market Growth (Status and Outlook) 2023-2029

Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.

LPI (LP Information)' newest research report, the “Botanical and Plant Derived Drugs Industry Forecast” looks at past sales and reviews total world Botanical and Plant Derived Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Botanical and Plant Derived Drugs sales for 2023 through 2029. With Botanical and Plant Derived Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Botanical and Plant Derived Drugs industry.

This Insight Report provides a comprehensive analysis of the global Botanical and Plant Derived Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Botanical and Plant Derived Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Botanical and Plant Derived Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Botanical and Plant Derived Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Botanical and Plant Derived Drugs.

The global Botanical and Plant Derived Drugs market size is projected to grow from US$ 27530 million in 2022 to US$ 35580 million in 2029; it is expected to grow at a CAGR of 3.7% from 2023 to 2029.

Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.

This report presents a comprehensive overview, market shares, and growth opportunities of Botanical and Plant Derived Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Tablets
Capsules
Pills
Injections

Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm

Please note: The report will take approximately 2 business days to prepare and deliver.